UNSPSC 51162730: Nesosteine

This classification denotes a mucolytic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 445J9K442Z. European Medicines Agency schedules Nesosteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09208MIG. Nesosteine generally arises in the molecular formula C11H11NO3S.

UNSPSC 51162730 Nesosteine is a Commodity code under which state and local governments procure parenteral pharmaceutical products and related healthcare delivery services for institutional settings, including intravenous solutions, total parenteral nutrition (TPN) and peripheral parenteral nutrition (PPN) preparations, naloxone, and drug deactivation systems. The Washington State Department of Corrections and Seminole County, Florida have posted recent solicitations under this code for pharmaceutical supply and clinical support services to correctional facilities and community health programs. Work solicited includes preparation and delivery of customized parenteral nutrition formulations with rapid turnaround requirements, monitoring of patient lab results and adjustment of PN preparations, quarterly supply deliveries of naloxone and drug deactivation systems, and compliance with clinical protocols specific to each institutional customer. Issuing bodies include state corrections departments and county health or public safety agencies, with primary buyers being state-level healthcare systems serving incarcerated populations and county community health programs.

The Washington State Department of Corrections (RFQQK13020, RFQ, response due October 7, 2026) is soliciting parenteral products, services, and equipment for eight correctional facilities across three regions, with a contract term running November 26, 2026 through June 30, 2030 and DOC retaining discretionary extension rights. DOC encourages participation from businesses certified as small, minority-owned, women-owned, or veteran-owned under Washington state programs, with an aspirational 5% Small and Diverse Business Goal. Seminole County, Florida (IFB60459723LAS, IFB, response due July 26, 2023) issued a separate solicitation for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, under a two-year initial term with one-year renewal option. Recent activity under this code is concentrated in Washington state and Florida, with state-level corrections departments representing the more active buyer segment for parenteral nutrition services requiring clinical expertise and rapid fulfillment.